Eastman Chemical [EMN] vs Linde plc [LIN] Detailed Stock Comparison
Eastman Chemical
NYSE
Loading...
Linde plc
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Eastman Chemical wins in 8 metrics, Linde plc wins in 12 metrics, with 0 ties. Linde plc appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Eastman Chemical | Linde plc | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 9.29 | 34.37 | Eastman Chemical |
| Price-to-Book Ratio | 1.30 | 5.86 | Eastman Chemical |
| Debt-to-Equity Ratio | 90.60 | 60.56 | Linde plc |
| PEG Ratio | -0.25 | 27.90 | Eastman Chemical |
| EV/EBITDA | 6.79 | 18.94 | Eastman Chemical |
| Profit Margin (TTM) | 8.96% | 20.02% | Linde plc |
| Operating Margin (TTM) | 12.42% | 28.29% | Linde plc |
| EBITDA Margin (TTM) | 12.42% | 28.29% | Linde plc |
| Return on Equity | 14.39% | 17.01% | Linde plc |
| Return on Assets (TTM) | 5.54% | 6.96% | Linde plc |
| Free Cash Flow (TTM) | $688.00M | $4.93B | Linde plc |
| Dividend Yield | 3.31% | 1.58% | Eastman Chemical |
| 1-Year Return | -34.51% | 3.21% | Linde plc |
| Price-to-Sales Ratio (TTM) | 0.82 | 6.74 | Eastman Chemical |
| Enterprise Value | $12.52B | $242.90B | Linde plc |
| EV/Revenue Ratio | 1.35 | 7.36 | Eastman Chemical |
| Gross Profit Margin (TTM) | 22.13% | 48.75% | Linde plc |
| Revenue per Share (TTM) | $80 | $69 | Eastman Chemical |
| Earnings per Share (Diluted) | $7.11 | $13.76 | Linde plc |
| Beta (Stock Volatility) | 1.23 | 0.97 | Linde plc |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Eastman Chemical vs Linde plc Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Eastman Chemical | 5.15% | -0.59% | -14.80% | -18.99% | -33.13% | -25.43% |
| Linde plc | 0.20% | 0.64% | 2.19% | 5.53% | 4.96% | 16.07% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Eastman Chemical | -34.51% | -30.55% | -11.31% | -9.21% | 116.00% | 172.54% |
| Linde plc | 3.21% | 67.93% | 89.58% | 352.69% | 450.77% | 892.79% |
Performance & Financial Health Analysis: Eastman Chemical vs Linde plc
| Metric | EMN | LIN |
|---|---|---|
| Market Information | ||
| Market Cap | $7.58B | $222.60B |
| Market Cap Category | Mid cap | Mega cap |
| 10 Day Avg. Volume | 1,553,501 | 1,460,950 |
| 90 Day Avg. Volume | 1,729,367 | 1,675,487 |
| Last Close | $69.41 | $481.67 |
| 52 Week Range | $56.78 - $114.50 | $408.65 - $487.49 |
| % from 52W High | -39.38% | -1.19% |
| All-Time High | $130.47 (May 31, 2021) | $487.49 (Oct 14, 2024) |
| % from All-Time High | -46.80% | -1.19% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.03% | 0.00% |
| Quarterly Earnings Growth | -0.39% | 0.03% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 0.20% |
| Operating Margin (TTM) | 0.12% | 0.28% |
| Return on Equity (TTM) | 0.14% | 0.17% |
| Debt to Equity (MRQ) | 90.60 | 60.56 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $50.84 | $80.70 |
| Cash per Share (MRQ) | $3.69 | $11.23 |
| Operating Cash Flow (TTM) | $1.00B | $9.63B |
| Levered Free Cash Flow (TTM) | $381.75M | $3.41B |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.31% | 1.58% |
| Last 12-Month Dividend | $2.47 | $7.28 |
Valuation & Enterprise Metrics Analysis: Eastman Chemical vs Linde plc
| Metric | EMN | LIN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 9.29 | 34.37 |
| Forward P/E | 7.59 | 27.90 |
| PEG Ratio | -0.25 | 27.90 |
| Price to Sales (TTM) | 0.82 | 6.74 |
| Price to Book (MRQ) | 1.30 | 5.86 |
| Market Capitalization | ||
| Market Capitalization | $7.58B | $222.60B |
| Enterprise Value | $12.52B | $242.90B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.35 | 7.36 |
| Enterprise to EBITDA | 6.79 | 18.94 |
| Risk & Other Metrics | ||
| Beta | 1.23 | 0.97 |
| Book Value per Share (MRQ) | $50.84 | $80.70 |
Financial Statements Comparison: Eastman Chemical vs Linde plc
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EMN | LIN |
|---|---|---|
| Revenue/Sales | $2.29B | $8.11B |
| Cost of Goods Sold | $1.72B | $4.16B |
| Gross Profit | $567.00M | $3.96B |
| Research & Development | $67.00M | $38.00M |
| Operating Income (EBIT) | $318.00M | $2.22B |
| EBITDA | $442.00M | $3.15B |
| Pre-Tax Income | $253.00M | $2.18B |
| Income Tax | $70.00M | $511.00M |
| Net Income (Profit) | $183.00M | $1.71B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EMN | LIN |
|---|---|---|
| Cash & Equivalents | $418.00M | $5.29B |
| Total Current Assets | $3.90B | $13.60B |
| Total Current Liabilities | $2.27B | $14.49B |
| Long-Term Debt | $4.74B | $17.61B |
| Total Shareholders Equity | $5.94B | $39.46B |
| Retained Earnings | $10.10B | $13.55B |
| Property, Plant & Equipment | $14.13B | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EMN | LIN |
|---|---|---|
| Operating Cash Flow | $-167.00M | $2.34B |
| Capital Expenditures | $-147.00M | N/A |
| Free Cash Flow | $-314.00M | $891.00M |
| Debt Repayment | $-550.00M | $-1.01B |
| Common Stock Repurchase | N/A | $-1.11B |
Short Interest & Institutional Ownership Analysis
| Metric | EMN | LIN |
|---|---|---|
| Shares Short | 2.66M | 5.14M |
| Short Ratio | 1.67 | 2.93 |
| Short % of Float | 0.03% | 0.01% |
| Average Daily Volume (10 Day) | 1,553,501 | 1,460,950 |
| Average Daily Volume (90 Day) | 1,729,367 | 1,675,487 |
| Shares Outstanding | 115.17M | 473.24M |
| Float Shares | 113.76M | 469.47M |
| % Held by Insiders | 0.01% | 0.00% |
| % Held by Institutions | 0.91% | 0.88% |
Dividend Analysis & Yield Comparison: Eastman Chemical vs Linde plc
| Metric | EMN | LIN |
|---|---|---|
| Last 12-Month Dividend | $2.47 | $7.28 |
| Last 12-Month Dividend Yield | 3.31% | 1.58% |
| 3-Year Avg Annual Dividend | $2.94 | $5.83 |
| 3-Year Avg Dividend Yield | 0.92% | 0.34% |
| 3-Year Total Dividends | $8.82 | $17.48 |
| Ex-Dividend Date | Mar 14, 2025 | Sep 04, 2025 |